A new AI approach for breast cancer imaging, RST2G, was reported to improve dynamic contrast-enhanced MRI (DCE-MRI) segmentation performance by combining residual-guided spatiotemporal transformer graph fusion. The method focuses on delineating breast tumor boundaries, a key step that depends on accurate interpretation of enhancement kinetics. The work emphasizes the clinical problem of heterogeneity in tumor morphology and enhancement patterns, which can reduce consistency in automated contouring. By fusing spatiotemporal information with residual guidance, RST2G is designed to strengthen segmentation accuracy across varying tumor presentations. The report frames the model as part of a growing category of medical-imaging AI systems designed for radiology workflows rather than post hoc image review. For oncologists and imaging groups, stronger segmentation algorithms can translate into more consistent response assessment and trial endpoints across DCE-MRI studies.